
FDA Approves Updated COVID Shots for 2026–27 Season
The FDA has approved updated COVID-19 vaccines from Moderna, Pfizer, and Novavax for the 2026–2027 season, all targeting the XFG variant. Distribution will begin soon, with eligibility continuing to favor older adults and people with high-risk conditions, while vaccination remains available to others. The vaccines use the flexible mRNA platform for rapid redesign and aim to prevent severe illness, hospitalization, and death, with benefits varying by individual risk.



